S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
Sell every Stock except ONE (Ad)
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
Sell every Stock except ONE (Ad)
Ruptured oil pipeline off California approved for repairs
Brazil holds historic election with Lula against Bolsonaro
Sell every Stock except ONE (Ad)
Allies aim for risky Russian oil price cap as winter nears
Italy's Meloni vows to put national energy interests first
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
Sell every Stock except ONE (Ad)
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
Sell every Stock except ONE (Ad)
Ruptured oil pipeline off California approved for repairs
Brazil holds historic election with Lula against Bolsonaro
Sell every Stock except ONE (Ad)
Allies aim for risky Russian oil price cap as winter nears
Italy's Meloni vows to put national energy interests first
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
Sell every Stock except ONE (Ad)
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
Sell every Stock except ONE (Ad)
Ruptured oil pipeline off California approved for repairs
Brazil holds historic election with Lula against Bolsonaro
Sell every Stock except ONE (Ad)
Allies aim for risky Russian oil price cap as winter nears
Italy's Meloni vows to put national energy interests first
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
Sell every Stock except ONE (Ad)
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
Sell every Stock except ONE (Ad)
Ruptured oil pipeline off California approved for repairs
Brazil holds historic election with Lula against Bolsonaro
Sell every Stock except ONE (Ad)
Allies aim for risky Russian oil price cap as winter nears
Italy's Meloni vows to put national energy interests first
NASDAQ:CEMI

Chembio Diagnostics - CEMI Stock Forecast, Price & News

$0.36
-0.06 (-14.24%)
(As of 09/30/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.33
$0.45
50-Day Range
$0.35
$1.10
52-Week Range
$0.33
$2.55
Volume
575,675 shs
Average Volume
928,548 shs
Market Capitalization
$12.79 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
CEMI stock logo

About Chembio Diagnostics (NASDAQ:CEMI) Stock

Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, lassa, marburg, leptospirosis, rickettsia, and Burkholderia diseases. The company sells its products under the STAT-PAK, SURE CHECK, STAT VIEW, and DPP trademarks, as well as sells its products directly through distributors to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medical professionals, and retail establishments in the United States and internationally. It has collaboration agreements with Bill & Melinda Gates Foundation, The Paul G. Allen Family Foundation, The Oswaldo Cruz Foundation, and the Foundation for Innovative New Diagnostics, as well as U.S. government agencies, such as Centers for Disease Control and Prevention, the Biomedical Advanced Research and Development Authority of the U.S. Department of Health and Human Services, and the U.S. Department of Agriculture. Chembio Diagnostics, Inc. was founded in 1985 and is headquartered in Hauppauge, New York.

Receive CEMI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chembio Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

CEMI Stock News Headlines

Chembio Expands Distribution
Chembio Diagnostics Q1 2022 Earnings Preview
Why Chembio Diagnostics Shares Are Falling
Chembio Diagnostics Q4 2021 Earnings Preview
Chembio Diagnostics, Inc. Common Stock (CEMI)
Chembio Diagnostics appoints CFO
Pre-market Movers: PIXY, NEW, CEMI, SYTA, AUVI…
See More Headlines
Receive CEMI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chembio Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

CEMI Company Calendar

Last Earnings
11/04/2021
Today
10/02/2022
Next Earnings (Estimated)
11/03/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:CEMI
Employees
337
Year Founded
N/A

Profitability

Net Income
$-33,900,000.00
Pretax Margin
-59.50%

Debt

Sales & Book Value

Annual Sales
$47.82 million
Book Value
$1.14 per share

Miscellaneous

Free Float
34,224,000
Market Cap
$12.79 million
Optionable
Not Optionable
Beta
1.65

Key Executives

  • Mr. Richard L. Eberly (Age 61)
    Pres, CEO & Director
    Comp: $664.13k
  • Mr. Javan Esfandiari (Age 55)
    Exec. VP and Chief Scientific & Technology Officer
    Comp: $508.22k
  • Mr. Lawrence J. Steenvoorden CPA (Age 51)
    Exec. VP, CFO & Sec.
  • Mr. Paul J. Angelico (Age 65)
    EVP & COO
  • Ms. Stella Rivera
    VP of HR
  • Mr. Charles Caso (Age 60)
    Sr. VP of Global Commercial Operations
  • Dr. Konstantin Lyashchenko
    Research Director of Chembio Diagnostic Systems Inc













CEMI Stock - Frequently Asked Questions

Should I buy or sell Chembio Diagnostics stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chembio Diagnostics in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" CEMI shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CEMI, but not buy additional shares or sell existing shares.
View CEMI analyst ratings
or view top-rated stocks.

How have CEMI shares performed in 2022?

Chembio Diagnostics' stock was trading at $1.14 at the start of the year. Since then, CEMI shares have decreased by 68.3% and is now trading at $0.3614.
View the best growth stocks for 2022 here
.

When is Chembio Diagnostics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our CEMI earnings forecast
.

How were Chembio Diagnostics' earnings last quarter?

Chembio Diagnostics, Inc. (NASDAQ:CEMI) announced its quarterly earnings data on Thursday, November, 4th. The company reported ($0.24) EPS for the quarter, missing analysts' consensus estimates of ($0.19) by $0.05. The firm earned $12.06 million during the quarter. Chembio Diagnostics had a negative net margin of 59.52% and a negative trailing twelve-month return on equity of 96.63%. During the same period in the previous year, the business earned ($0.28) EPS.

What other stocks do shareholders of Chembio Diagnostics own?
What is Chembio Diagnostics' stock symbol?

Chembio Diagnostics trades on the NASDAQ under the ticker symbol "CEMI."

How do I buy shares of Chembio Diagnostics?

Shares of CEMI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Chembio Diagnostics' stock price today?

One share of CEMI stock can currently be purchased for approximately $0.36.

How much money does Chembio Diagnostics make?

Chembio Diagnostics (NASDAQ:CEMI) has a market capitalization of $12.79 million and generates $47.82 million in revenue each year. The company earns $-33,900,000.00 in net income (profit) each year or ($1.23) on an earnings per share basis.

How many employees does Chembio Diagnostics have?

The company employs 337 workers across the globe.

How can I contact Chembio Diagnostics?

Chembio Diagnostics' mailing address is 555 WIRELESS BLVD., HAUPPAUGE NY, 11788. The official website for the company is www.chembio.com. The company can be reached via phone at (631) 924-1135, via email at investor@chembio.com, or via fax at 631-924-2065.

This page (NASDAQ:CEMI) was last updated on 10/2/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.